your market intelligence analyst
Search Results
Edit Save
1,154 results
SynBioBeta 08/04/2020 11:31
CAMBRIDGE, Mass. and SOMERSET, N.J., July 29, 2020 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that they have entered into a strategic [...]. .
SynBioBeta 08/04/2020 10:58
DURHAM, N.C., Aug. 04, 2020 (GLOBE NEWSWIRE) — Elo Life Systems, a food and agriculture company with a mission to improve human health and wellness, today announced a strategic partnership with the Dole Food Company, one of the world’s largest producers of high-quality fresh fruit and vegetables, aiming to develop multiple banana varieties, including Cavendish, [...]. .
SynBioBeta 08/04/2020 05:17
When breastfeeding isn’t an option, a new bioengineering-enabled formula may be the next best thing The benefits of breastfeeding are well-known. It provides essential nutrition, boosts a baby’s immune system, and supports physical and emotional development in the early years. Breastfeeding even has wider environmental and economic benefits for our communities. Yet the Centers for Disease Control report that only 25 percent of U.S. […]. .
SynBioBeta 08/04/2020 03:05
Impossible Burger is a household name best recognized for its successful introduction of a plant-based burger that “bleeds” and has no animal hormones or antibiotics. But, there is another notable “first” for Impossible Burger—it is the first product in stores to adopt the new USDA-approved “bioengineered” GMO (genetically modified organism) product label that will soon […]. .
SynBioBeta 08/03/2020 09:17
– Plans to Initiate Phase 1 Clinical Trial This Year – Expands Corporate Advisors with Board of Directors and Scientific Advisory Board Appointments PHILADELPHIA, July 27, 2020 /PRNewswire/ — CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug [...]. .
SynBioBeta 08/02/2020 04:00
8VC’s Francisco Gimenez, Ph.D., Joins Company Board of Directors SAN FRANCISCO, July 29, 2020 /PRNewswire/ — Mantra Bio today announced it has raised $25 million in a Series A financing to advance development of next generation, precision therapeutics based on its proprietary platform for engineering Targeted Exosome Vehicles (TEVs).
SynBioBeta 08/02/2020 01:51
–Next-wave engineered protein company with pipeline of cytokine therapeutics developed in Versant’s Ridgeline Discovery Engine– –First IL-2 development candidate shows superior properties to all known competitors– –Industry veteran Sef Kurstjens joins as president and CEO– July 28, 2020 08:00 AM Eastern Daylight Time BASEL, Switzerland & SAN DIEGO–(BUSINESS WIRE)–Versant Ventures today announced the debut of [...]. .
SynBioBeta 08/01/2020 04:40
Most of us want the government and brands to prioritize sustainability even while facing other issues. When the coronavirus shutdown hit California, San Diego-based clean manufacturing firm Genomatica sent its desk workers home to work remotely, which gave more room to its lab workers to maintain physical distance from one another. As the weeks went on, Genomatica’s co-founder and CEO, […]. .
SynBioBeta 07/30/2020 09:16
Many of us are asking: Have I already been exposed to the coronavirus, and am I immune to further infection? A fast, easy, and sensitive new antibody test detects the specific biomarkers of long-term immune protection against SARS-CoV-2 that can answer that question. If Covid is here for the foreseeable future—and the waves of infections […]. .
SynBioBeta 07/29/2020 06:35
— Panel 1 Targets SARS-CoV-2 Spike Protein; Panel 2 Targets Human ACE2 — July 28, 2020 08:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the availability of two new SARS-CoV-2 [...]. .
SynBioBeta 07/29/2020 06:15
CAMBRIDGE, Mass. and PETACH TIKVAH, Israel, July 28, 2020 (GLOBE NEWSWIRE) — Manus Bio Inc. (Manus Bio), a leader in the production of complex natural products through advanced bio-fermentation, and STK Bio-Ag Technologies (STK), an innovator of botanical and ‘hybrid’ crop protection solutions, are announcing a collaboration agreement to develop and commercialize a series of [...]. .
SynBioBeta 07/29/2020 06:12
PHILADELPHIA and DENVER, July 07, 2020 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, and Artisan Bio, Inc., a precision cell therapy engineering company, today announced they have signed a research and collaboration [...]. .
SynBioBeta 07/29/2020 06:10
Casdin Capital leads the $50M extension; funding will support commercial launch of SYNTAX™ the world’s first enzymatic DNA printer. July 29, 2020 03:00 AM Eastern Daylight Time PARIS & SOUTH SAN FRANCISCO–(BUSINESS WIRE)–DNA Script today announced a $50 million extension to its Series B financing, bringing the total investment of this round to $89 million. […]. .
SynBioBeta 07/27/2020 12:57
Join Alex Lorestani (CEO, Geltor) to discuss how and why brands and manufacturers serving the $500B global beauty market are increasingly turning to biology for solutions, and what that could mean for the future. While the promise of biotechnology has been speculated upon for applications in pharmaceuticals, agriculture, and nutrition, its foothold in beauty and […]. .
SynBioBeta 07/27/2020 08:46
EMERYVILLE, Calif., July 27, 2020 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets and IDRI (Infectious Disease Research Institute) today announce the signing of a binding term sheet for a planned COVID-19 RNA (ribonucleic acid) vaccine technology program.
SynBioBeta 07/25/2020 06:26
Publication in peer-reviewed journal Science demonstrates the foundation of the company’s evolution-based, data-driven engineering technology to build artificial functional enzymes CHICAGO, July 23, 2020 /PRNewswire/ — A publication released in the peer-review journal Science today demonstrates the foundation of Evozyne’s evolution-based, data-driven engineering process for building artificial functional enzymes.
SynBioBeta 07/24/2020 07:48
Major funding announcement for all-star Australian skin-printing team, Inventia Skin, that could transform skin regeneration and current approaches to skin therapy and wound management. SYDNEY (PRWEB) JULY 23, 2020 A team including fast-growing Sydney start-up Inventia Life Science, world renowned skin surgeon and former Australian of the Year, Professor Fiona Wood, and leading bioprinting researcher, Professor […]. .

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications